The groundbreaking approach of tirzepatide peptide represents a major development in the management of the condition. Unlike existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – leading to https://tirzepatidepeptide035906.tusblogos.com/42701286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment